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Objeedves . The purpose of this study was to document the
varkm causes of dilated cardlomyopalby in a large gro,up of adult
patienis pith congestive hurt failure .
Background. 1'revicius reports of the causes of dilated cardio-
Wyqm%y hot unally bum cot nNtpeartu of a single spwific
or
review articles. The frequency of any single specific heart
nimtk- & -, znas4, is largely unknown.
Methods . We evaluated 673 patients referred for congestive
heart f4pare due to dilated cardlomyopathy. The evaluation
included medical history, physical imandsation, routine b
chemistry and hematologic measurements, clectrocalrdlography
and echocardlography . Thyroid function tests, antinuclear anti
.
bady tess and urinary vamillyinandelic acid and metanephrine
levels were also obtaineed . Endomyocardial biopsy with right heart
Cardiac dilation with left ventricular systolic dysfunction,
which we have called dilated cardiomyopathy, is the most
common cause of congestive heart failure (1) . This disorder
has many causes including idiopathic dilated cardiomyopa-
thy, which we have defined as a primary heart muscle
disease of unknown cause. The purpose of this study was to
review the causes of dilated cardiomyopathy in a large
unselected group of adult patients referred for the evaluation
of congestive heart failure .
Methods
Subjects. Between December 79, 1982 and December 31,
1991, 673 patients were evaluated by The Johns Hopkins
Hospital Cardiomyopathy Service for congestive heart fail-
ure due to dilated cardiomyopathy. The patients usually
dated the onset of symptoms to within the previous 6
months. The majority (83%) of patients referred for evalua-
tion had dilated cardionnyopathy, and all of these patients
were included in this study .
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catheterization was performed in every patient . Coronary arte-
rhqpzphy was performed In patients who had at least two
standard
cardiovascular risk factors or a history suggestive of
myeardial Ischentla. The cam were retrospectively reviewed,
and a final cause for dilated cardlomyopathy was listed for each
patient.
Results . The most common causes of dilated cardiomyopathy
were idiopathic origin (47%), idiopathic myocarditis (12%) and
coronary artery disease (11%) . The other identifiable causes of
dilated cardlomyopothy made up 31% of the total cases .
Conclusions. Idiopathic dilated cardiomyopathy is a common
cause of congestive heart failure . Specific heart muscle diseases
occur with much less frequency .
(J Am Coil Cordial 1994,23 .586-90)
Protocol. The initial evaluation included a medical his-
tory, physical examination, routine blood chemistry and
hematologic measurements, electrocardiography and echo-
cardiography . The medical history included specific ques-
tions related to the cause of the cardiomyopathy, such as the
amount of alcohol consumed per day. Thyroid function
tests, antinuclear antibody titers and urinary vanillylman-
delic acid and metanephrine levels were measured to evalu-
ate specific heart muscle diseases . Coronary angiogniphy
was performed in patients with a history suggestive of
myocardial ischemia or in the presence of at least two
standard cardiovascular risk factors . These risk factors
included age >35 years, hypertension, hypercholesterol-
emia, a positive family history of early coronary artery
disease, diabetes mellitus, male gender and tobacco use .
Endomyocardial biopsy was performed in all 673 pa-
tients, preferably by way of the right internal jugular vein
with the use of a Stanford-Caves bioptome . At least four
specimens were obtained from the right side of the ventric-
ular septum . The tissue was immediately placed in either
10 formalin for light microscopy or 3% glutaraldehyde for
electron microscopy . A separate sample was fresh-frozen for
immunoperoxidase staining. Each specimen, stained with
hematoxylin-eosin for light microscopy, was examined at a
minimum of four levels by one investigator (G.M.H.) . Spe-
cial stains, such as Congo red for amyloid, were used when
appropriate. Immunoperoxidase stains performed on the
fresh-frozen tissue included stains for common leukocyte
0735-1097/94/$7.00
Unless otherwise indicated, values represented are mean value ± SD or
number
(°1c)
of patients .
antigen and T-lymphucyte subsets, as well as class I and 11
antigen expression . Only the initial biopsy procedure was
considered for analysis if the patient underwent a follow-up
biopsy. After endomyocardial biopsy. 607 patients (90%)
had right-sided cardiac catheterization performed with a
fluid-filled, balloon-tipped, flow-directed catheter attached
to a quartz transducer . Cardiac output was determined with
the thermodilution technique performed in triplicate with
<10% variability between determinations . Cardiac index
was calculated in the usual manner .
Definitions. Standardized diagnostic criteria were used .
The diagnostic categories were expanded from criteria de-
veloped by Coughlin et al . (2), utilizing the World Health
Organization (WHO) Task Force recommendations on the
Definition and Classification of Cardiomyopathies (3) . The
WHO Task Force did not include histologic examination of
cardiac tissue as part of their classification . The definitions
used in the present study are included in the Appendix .
Data analysis . A final diagnosis was recorded for each
patient at completion of the evaluation . These diagnoses
were retrospectively reviewed separately by two of us
(E. K . K ., K . L . B .) to ensure accuracy . Differences of opinion
were settled through discussion . The results were prospec-
tively computerized for tabulation . Results are expressed as
mean value 47 SEM.
Results
Patient characteristics (Table 1). A total of 673 consecu-
tive patients were evaluated for congestive heart failure due
to dilated cardiomyopathy . Their baseline characteristics are
presented in Table 1 . Most patients were adult men. Endo-
myocardial biopsy was performed by way of the right
internal jugular vein in 656 patients (97%) ; an average of
6 ± 2
specimens/patient
were obtained. Coronary arteriog-
raphy was part of the evaluation in 220 patients (33%) .
Final diagnoses (Table 2)
. The most common final diag-
noses were idiopathic dilated cardiomyopathy, idiopathic
myocarditis and coronary artery disease (ischemic cardio-
myopathy) . Myocarditis associated with a systemic disease
such as systemic lupus erythematosus, human immunodefi-
ciency virus (HIV) or peripartum cardiomyopathy was not
included in the category of idiopathic myocarditis . There
were 30 cases of borderline and 51 cases of active idiopathic
myocarditis .
In the "drug-induced" category, cardiomyopathy was
due to Adriamycin in nine patients, to cocaine in nine and vc
lithium, interleukin-2 and prednisone in one patient each (4) .
In the category of "connective tissue diseases," cardiomyo-
pathy was due to progressive systemic sclerosis in seven
patients, to systemic lupus erythematosus in five and to
polyarteritis nodosa, polymyositis and rheumatic carditis in
one patient each . Finally, in the metabolic category, cardio-
myopathy was due to hyperthyroidism in four patients, to
hypothyroidism in two, to hemochromatosis in three and to
pheochromocytorna in one patient .
There were 115 specific diagnoses (17%) made on endo-
myocardial biopsy : myocarditis (n
81), Adriamycin toxic-
ity (n = 9), cardiac amyloidosis (n 14), cardiac sarcoidosis
(n = 4), cardiac hemochromatosis (n = 3), endomyocardial
fibroelastosis (n = 1), histiocytosis X (n = 1), rheumatic
carditis (n = 1) and thrombotic thrombocytopenic purpura
(n = 1) .
Discussion
This is the largest report of unselected adult patients with
congestive heart failure due to dilated cardiomyopathy eval-
uated at a center with a specialized interest in cardiomyop-
athy . All patients underwent endomyocardial biopsy
. An
etiology for the dilated cardiomyopathy was found in 360
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Table 1. Characteristics of the 673 Study Patients
Men 423 (63)
Age (yr)
Mean
45 ± 15
Range 9-85
No. 00 yr 19 (3)
No. aT yr 24(4)
Right atrial mean pressure (mm Hg)
7 ± 6
Mean wedge pressure (mm ft 17 ± 10
Cardiac output (liters/min) 4 .5 ± 1 .1
Cardiac index (liters/min per m 2 .3 ± 0 .7
Blood pressure (mm Hg)
123 2: 24/78 ± 14
Heart rate (mm Hg)
91 ± 19
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Table 2 . Final Diagnoses
Frequency
Idiopathic dilated cardiomyopathy
313 46.5
Idiopathic myocarditis
81 12 .0
Coronary artery disease 74
11 .0
Human immunodeficiency virus 33 4 .9
Peripartum cardiomyopathy
33 4 .9
Chronic alcohol abuse 23 3 .4
Drug-induced cardiomyopathy (see text)
21 3 .1
Connective tisue diseases (see text)
15 2 .2
Amyloidosis 14
2 .1
Hypertension 14 2 .1
Familial cardiomyopathy
12 1 .8
Metabolic (see text) 10 1 .5
Valvular myopathy 10 1 .5
Congenital heart disease 4 0 .6
Neuromuscular diseases 4
0 .6
l"osicoropary bypass surgery 4 0 .6
Sarcoidosis 4 0 .6
Atrial fibrillation I 0 .1
Endomyocardial fibroelastosis
I 0 .1
Histiocytosis X 1 11 .1
Thrombolic thrombocytopenic purpura 1 0 .1
Total 673
KASPER ET AL
.
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(53%) of the 673 patients; an idiopathic origin was diagnosed
in the other 313 patients (47%)
. Most previous studies of the
causes of dilated cardiomyopathy have been case reports
concentrating on a single etiology . This study documents the
frequencies of various causes of dilated cardiomyopathy in a
large sample of adult patients with symptomatic congestive
heart failure .
Several etiologies deserve special mention. Although the
patients underwent an extensive search for specific causes of
dilated cardiomyopathy, the condition was most commonly
of idiopathic origin in this patient sample . Coronary artery
disease was uncommon 0M, a finding that probably rep®
resents selection bias because patients with an ischemic
cardiomyopathy might not have been referred for evalua-
tion . In a primary cam population, ischemic cardiomyopathy
plays a much greater role (1). Similarly, the frequency of
familial cardiomyopathy in this sample (1.8%) was smaller
than previously reported (5), a difference that may have been
due to our narrow definition of familial cardiomyopathy . A
high incidence of bopsy-proved myocarditis was found in
patients with both peripartum cardiomyopathy (74%) and
HIV-related cardiomyopathy (56%) . The relatively high fre-
quency of both HIV-related cardiomyopathy and peripartum
cardiomyopathy probably represents our interest in these
disorders. Similarly, The Johns Hopkins Hospital serves an
inner city population with a high prevalence of both cocaine
and alcohol abuse . The single patient with dilated cardio-
myopathy due to atrial fibrillation recovered normal cardiac
function with conversion to normal sinus rhythm . His heart
rate was not well controlled during atrial fibrillation .
Utility of endomyocardial biopy . There is considerable
controversy regarding the usefulness of endomyocardial
biopsy. Monitoring for cardiac allograft rejection and anthra .
cycline cardiotoxicity are the most widely accepted indica-
tions for endomyocardial biopsy (6) . We were not able to
address this question in the current study . The number of
specific histologic diagnoses made on endomyocardial bi-
opsy was 115 (17%) . The utility of endomyocardial biopsy
remains unclear.
Study limitations. Unlike previous studies, the present
study used standardized clinical and pathologic diagnostic
criteria. We tried to use criteria that were well established or
at least agreed on by all of the authors . The existence of
some categories, such as hypertensive cardiomyopathy and
corticosteroid cardiomyopathy, are controversial . Similarly .
arbitrary decisions were necessary in setting the defining
characteristics of some categories.
Heart muscle disease may have multiple causes in any
single patient with dilated cardiomyopathy . Although a
single factor may predominate, this should not restrict the
search for other potential causes that may exacerbate the
condition. For example, a patient may have well developed
ischemic cardiomyopathy worsened by a recent increase in
alcohol consumption or the development of hypothyroidism .
All patients studied had been referred to The Johns
Hopkins Hospital Cardiomyopathy Service for evaluation of
JACC Vol. 23 . No . 3
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dilated cardiomyopathy . The Johns Hopkins Hospital is a
tertiary care referral center that also serves a large primary
care population . The majority (64%) of patients were re-
ferred to us by other cardiologists . These data are probably
representative of other tertiary care institutions with a
similar patient population . Se!ection bias limits the applica-
bility of these data to primary care populations . Similarly,
the patients studied had symptomatic congestive heart fail-
ure. The causes of dilated cardiomyopathy might be different
in asymptomatic patients .
Appendix
Deftttilit)ns
Idiopathic dilated cardiomyopathy . All patients with idiopathic
dilated cardiomyopathy had a left ventricular diastolic diameter of
~6 cm, with diffuse hypokinesia or akinesia and an ejection fraction
<NXv,. They did not have clinical evidence of hypertensive, valvu-
lar, ischemic or congenital heart disease (7-11) . A biopsy showing
nonspecific changes, such as myocyte hypertrophy, nuclear abnor-
malities or interstitial fibrosis, was necessary for a diagnosis of
idiopathic dilated cardiomyopathy (11) . Patients with a normal
biopsy result were excluded from this category because it was
possible that they had a patchy process, such as myocardial sarcoid,
that was missed because of sampling error .
Extrankyao -ardial. Patients with hypertensive cardiomyopathy
had a systolic blood pressure >200 mm Hg or a history of poorly
controlled hypertension of >5 years' duration (12,13) . Ischeinic
cardiomyopathy was defined by either a history of myocardial
infarction or >5017c occlusion of one or more coronary arteries
documented by coronary arteriography (14) . Replacement fibrosis
was often seen on endomyocardial biopsy . Patients with valvidar
cardiomyopathy due to mitral regurgitation had greater than grade
3/4 regurgitation, whereas patients with aortic regurgitation had
greater than grade 2/4 regurgitation by angiographic analysis (15) .
The vaivular regurgitation was known to have preceded the onset of
cardiomyopathy . Patients with aortic stenosis had a calculated valve
area
<
1 CM2 at cardiac catheterization (15) . Thr presence of
unrepaired congenital heart disease in the absence of other causes of
dilated cardiomyopathy defined the cardiomyopathy of congenital
heart disease. Cardiomyopathy associated with coronary artery
bypass surgery was defined by new onset of cardiomyopathy after
such surgery .
Myocarditis . Active or borderline myocarditis was a histologic
diagnosis made according to the Dallas criteria (16) . hence an
endomyocardial biopsy was required . The diagnosis was confirmed
by immunoperoxidase staining (>10 common leukocyte antigen
positive cells per high power field).
Metabolic . Cardiomyopathy due to thyroid disease occurred in
patients with the appropriate abnormal thyroid function tests during
the year before the onset of cardiomyopathy . Improvement of
ventricular function with treatment of the thyroid disorder was
required (17-22) . Pheochromorytorna was diagnosed in patients
with a history of pheochromocytoma documented by elevated
urinary vanillylmandelic acid or metanephrine levels associated with
-..n abnormal adrenal mass, or surgical removal of a pheochromocy-
toma or treatment with the appropriate alpha- and beta-receptor
blocking agents (23,24). The diagnosis of hernochromarosis required
JACC Vol . 23, No . 3
March 1
. 1994 :586-40
biopsy evidence of excessive myocardial iron deposits . A diagnosis
of ankyloidosis required the presence of myocardial amyloid depos-
its (2516).
A diagnosis of collagen disease required clinical evidence of
Marfan or Ehlers-Danlos syndrome. Connective tissue disease was
diagnosed in patients with the appropriate clinical and laboratory
studies. This category included systemic lupus erythematosus,
polyarteritis nodosa, progressive systemic sclerosis, rheumatic car-
diomyopat1ky and mixed connective tissue disorder (27-29) . Sarcoid-
osis required pathologic evidence of myocardial noncaseating gran-
uloma in an appropriate clinical setting (30,31).
Neuromuscular disorder was defined by the presence of a
documented neuromuscular disease (32) . Familial cardiomyopathy
was diagnosed in the presence of clinical and anatomic evidence of
cardiomyopathy in at least ope first-degree relative (5,33,34) .
Drug-induced cardiomyopathy . Atahracycline cardiomyopathy
was diagnosed in patients with a history of receiving an anthracy-
cline during the year before the onset of the cardiomyopathy
associated with appropriate cardiac histologic findings (35-37) .
Heavy alcohol use, defined as the consumption of oz/day of
ethanol for ~6 months or the treatment of alcoholism or alcohol
withdrawal syndrome, was required for a diagnosis of a cardiomyo-
pathy due to alcohol (38-43) . Cocaine cardiomyopathy was defined
by a history of cocaine use or positive findings on a drug screen
(44-47) . A history of receiving any drug known to cause cardiomyo-
pathy (other than cocaine, ethanol or an anthracycline) before the
onset of the cardiomyopathy associated with an eosinophilic myo-
carditis-defined drug-induced cardiomyopathy .
Peripartum cardiomycpathy. This was diagnosed if the onset of
cardiomyopathy occurred during the last month of pregnancy or
within 5 months after delivery (48) . Human immunodeficiency, virus
(HIV)-induced c,-~iomyopathy was diagnosed in HIV-positive
patients by enzyme-linked immurosorbent assay (ELISA) and
Western blot analysis, without myocardial biopsy evidence of a
specific myocardial infection (49-51) . Neoplastic heart disease
required biopsy or autopsy evidence of neoplasm, primary or
metastatic, involving the myocardium (52) . Likewise, endonlyocar-
dial fibroelastosis required histopathologic evidence . Arrhythmia
required the recent onset of significant ventricular or supraventric-
ular arrhythmias associated with myocardial dysfunction that less-
ened with treatment of the arrhythmia .
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